Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T86528 | Target Info | |||
Target Name | Geranyltranstransferase (FDPS) | ||||
Synonyms | KIAA1293; Geranylgeranyl pyrophosphate synthase; Geranylgeranyl diphosphate synthase; GGPS1; GGPPSase; GGPP synthase; Farnesyltranstransferase; Farnesyl pyrophosphate synthase; Farnesyl diphosphate synthase; FPS protein; FPP synthase; Dimethylallyltranstransferase; (2E,6E)-farnesyl diphosphate synthase | ||||
Target Type | Successful Target | ||||
Gene Name | FDPS | ||||
Biochemical Class | Alkyl aryl transferase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | ({[6-(4-Methylphenyl)thieno[2,3-D]pyrimidin-4-Yl]amino}methanediyl)bis(Phosphonic Acid) | Ligand Info | |||
Canonical SMILES | CC1=CC=C(C=C1)C2=CC3=C(N=CN=C3S2)NC(P(=O)(O)O)P(=O)(O)O | ||||
InChI | 1S/C14H15N3O6P2S/c1-8-2-4-9(5-3-8)11-6-10-12(15-7-16-13(10)26-11)17-14(24(18,19)20)25(21,22)23/h2-7,14H,1H3,(H,15,16,17)(H2,18,19,20)(H2,21,22,23) | ||||
InChIKey | SFWLGYOMOJOLFV-UHFFFAOYSA-N | ||||
PubChem Compound ID | 71583208 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 4LPG Crystal structure of human FPPS in complex with CL01131 | ||||||
Method | X-ray diffraction | Resolution | 2.35 Å | Mutation | No | [1] |
PDB Sequence |
DVYAQEKQDF
17 VQHFSQIVRV27 LTEEMGHPEI38 GDAIARLKEV48 LEYNAIGGKY58 NRGLTVVVAF 68 RELVEPRKQD78 ADSLQRAWTV88 GWCVELLQAF98 FLVADDIMDS108 SLTRRGQICW 118 YQKPGVGLDA128 INDANLLEAC138 IYRLLKLYCR148 EQPYYLNLIE158 LFLQSSYQTE 168 IGQTLDLLTA178 PQGNVDLVRF188 TEKRYKSIVK198 YKTAFYSFYL208 PIAAAMYMAG 218 IDGEKEHANA228 KKILLEMGEF238 FQIQDDYLDL248 FGDPSVTGKI258 GTDIQDNKCS 268 WLVVQCLQRA278 TPEQYQILKE288 NYGQKEAEKV298 ARVKALYEEL308 DLPAVFLQYE 318 EDSYSHIMAL328 IEQYAAPLPP338 AVFLGLARKI348 Y
|
|||||
|
||||||
PDB ID: 4JVJ Crystal structure of human FPPS in complex with magnesium, CL01131, and sulfate | ||||||
Method | X-ray diffraction | Resolution | 2.80 Å | Mutation | No | [2] |
PDB Sequence |
DVYAQEKQDF
17 VQHFSQIVRV27 LTEDEMGHPE37 IGDAIARLKE47 VLEYNAIGGK57 YNRGLTVVVA 67 FRELVEPRKQ77 DADSLQRAWT87 VGWCVELLQA97 FFLVADDIMD107 SSLTRRGQIC 117 WYQKPGVGLD127 AINDANLLEA137 CIYRLLKLYC147 REQPYYLNLI157 ELFLQSSYQT 167 EIGQTLDLLT177 APQGNVDLVR187 FTEKRYKSIV197 KYKTAFYSFY207 LPIAAAMYMA 217 GIDGEKEHAN227 AKKILLEMGE237 FFQIQDDYLD247 LFGDPSVTGK257 IGTDIQDNKC 267 SWLVVQCLQR277 ATPEQYQILK287 ENYGQKEAEK297 VARVKALYEE307 LDLPAVFLQY 317 EEDSYSHIMA327 LIEQYAAPLP337 PAVFLGLARK347 IYK
|
|||||
|
PHE99
3.102
LEU100
4.601
ALA102
4.519
ASP103
2.796
MET106
3.766
ASP107
3.022
ARG112
2.382
THR167
3.283
GLU168
4.528
GLN171
2.910
ASP174
4.547
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Multistage screening reveals chameleon ligands of the human farnesyl pyrophosphate synthase: implications to drug discovery for neurodegenerative diseases. J Med Chem. 2014 Jul 10;57(13):5764-76. | ||||
REF 2 | Thienopyrimidine bisphosphonate (ThPBP) inhibitors of the human farnesyl pyrophosphate synthase: optimization and characterization of the mode of inhibition. J Med Chem. 2013 Oct 24;56(20):7939-50. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.